Chlorambucil effectively induces deletion mutations in mouse germ cells

Area of Science:

• Genetics
• Toxicology
• Molecular Biology

Background:

• Chemotherapeutic agents can induce mutations, impacting germ-line cells.
• Understanding mutagenic effects is crucial for assessing reproductive risks and developing targeted therapies.
• Previous studies have evaluated various chemicals and radiation for mutagenicity in mouse models.

Purpose of the Study:

• To evaluate the efficacy of chlorambucil in inducing germ-line mutations in mice.
• To compare the mutagenic potential of chlorambucil with x-rays and other chemicals.
• To characterize the types of mutations induced and identify sensitive germ-cell stages.

Main Methods:

• Exposure of male mice to chlorambucil (10-25 mg/kg) at various germ-cell stages.
• Scoring of 60,750 offspring for specific-locus mutations.
• Genetic, cytogenetic, and molecular analyses to confirm mutation types.

Main Results:

• Chlorambucil induced significant mutation rates in post-stem-cell stages, particularly early spermatids (approx. 1% at 10 mg/kg).
• No significant increase in mutation rates was observed in spermatogonial stem cells.
• Most induced mutations were confirmed as deletions or structural changes, differing from other chemical mutagens.

Conclusions:

• Chlorambucil is a potent inducer of germ-line deletions and structural mutations in mice, exceeding the efficacy of x-rays and other tested chemicals.
• The stage-specific response pattern of chlorambucil is unique among known mutagens.
• Chlorambucil is a promising mutagen for generating large-lesion mutations for molecular mapping and structure-function studies.